Similar to CCR4 antibodies, specialized antibodies against TARC/CCL17 and CCL22 can reduce ovalbumin (OVA)-induced airway eosinophilia and hypersensitivity reactions in asthmatic mice [59]. This evidence concerns the gene CCL17 and Increased total eosinophil count.